¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Á¦2ȸ ´ëÇÑÃéÀå´ãµµÇÐȸ&´ëÇÑ°£ÇÐȸ ÇÕµ¿½ÉÆ÷Áö¿ò : 2024-01-27

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

Á¦2ȸ ´ëÇÑÃéÀå´ãµµÇÐȸ&´ëÇÑ°£ÇÐȸ ÇÕµ¿½ÉÆ÷Áö¿ò : 2024-01-27
±³À°ÀÏÀÚ : 2024-01-27
±³À°Àå¼Ò : ¼­¿ï´ëÇб³º´¿ø ÀÇÇבּ¸Çõ½Å¼¾ÅÍ(CMI) ¼­¼ºÈ¯ ¿¬±¸È¦

±³À°ÁÖÁ¦ : Á¦2ȸ ´ëÇÑÃéÀå´ãµµÇÐȸ&´ëÇÑ°£ÇÐȸ ÇÕµ¿½ÉÆ÷Áö¿ò

ÁÖÃÖ±â°ü : ´ëÇÑÃé´ãµµÇÐȸ
´ã´çÀÚ : ¼ÛÀç¼ø
¿¬¶ôó : 02-2285-5145  

À̸ÞÀÏ : kpba@kams.or.kr

±³À°Á¾·ù : ³»°ú

Âü¼®¿¹»óÀÎ : 100¸í
Èñ¸ÁÆòÁ¡ : 2Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 3 ½Ã°£ 0ºÐ

¼¼ºÎ¼ö°­·á : 10,000¿ø  

ºñ°í »çÀüµî·Ï ¹«·á, ÇöÀåµî·Ï 10,000¿ø


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 01¿ù 27ÀÏ ¼­¿ï´ëº´¿ø CMI ¼­¼ºÈ¯ ¿¬±¸È¦ 13:30~13:50 Introduction to EUS-based endohepatology ÀÌÀç¹Î(°í·ÁÀÇ´ë)

±³À°½Ã°£ 01¿ù 27ÀÏ ¼­¿ï´ëº´¿ø CMI ¼­¼ºÈ¯ ¿¬±¸È¦ 13:50~14:10 Current situation and clinical application of interventional endoscopy Á¶ÀçÈñ(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 01¿ù 27ÀÏ ¼­¿ï´ëº´¿ø CMI ¼­¼ºÈ¯ ¿¬±¸È¦ 14:10~14:30 Clinical applications of contrast-enhanced ultrasound for focal liver lesions ÀÌÇö¿õ(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 01¿ù 27ÀÏ ¼­¿ï´ëº´¿ø CMI ¼­¼ºÈ¯ ¿¬±¸È¦ 14:30~14:50 Indications and challenges of transarterial radioembolization in hepatocellular carcinoma ÀÌÀ±ºó(¼­¿ïÀÇ´ë)

Åä·Ð 01¿ù 27ÀÏ ¼­¿ï´ëº´¿ø CMI ¼­¼ºÈ¯ ¿¬±¸È¦ 14:50~15:00 Discussion ( )

ÈÞ½Ä 01¿ù 27ÀÏ ¼­¿ï´ëº´¿ø CMI ¼­¼ºÈ¯ ¿¬±¸È¦ 15:00~15:20 Break ( )

±³À°½Ã°£ 01¿ù 27ÀÏ ¼­¿ï´ëº´¿ø CMI ¼­¼ºÈ¯ ¿¬±¸È¦ 15:20~15:40 ASH vs. MASH (NASH): pathomechanisms and therapeutic targets ¼®±âÅÂ(ÇѸ²ÀÇ´ë)

±³À°½Ã°£ 01¿ù 27ÀÏ ¼­¿ï´ëº´¿ø CMI ¼­¼ºÈ¯ ¿¬±¸È¦ 15:40~16:00 Pathogenesis, mechanisms, research and future directions in alcoholic pancreatitis Á¶ÁßÇö(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 01¿ù 27ÀÏ ¼­¿ï´ëº´¿ø CMI ¼­¼ºÈ¯ ¿¬±¸È¦ 16:00~16:20 Update on current and emerging strategies for the management of severe alcoholic hepatitis Á¤½Â¿ø(¼øõÇâÀÇ´ë)

±³À°½Ã°£ 01¿ù 27ÀÏ ¼­¿ï´ëº´¿ø CMI ¼­¼ºÈ¯ ¿¬±¸È¦ 16:20~16:40 Management of alcoholic pancreatitis Á¤¹Î±Ô(°æºÏÀÇ´ë)

Åä·Ð 01¿ù 27ÀÏ ¼­¿ï´ëº´¿ø CMI ¼­¼ºÈ¯ ¿¬±¸È¦ 16:40~16:50 Discussion ( )

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Á¦2ȸ ´ëÇÑÃéÀå´ãµµÇÐȸ&´ëÇÑ°£ÇÐȸ ÇÕµ¿½ÉÆ÷Áö¿ò : 2024-01-27""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2024³â Á¦13ȸ ¼º±Õ°ü´ëÇб³ »ï¼ºÃ¢¿øº´¿ø ³»°ú ¿¬¼ö°­Á : 2024-01-27
´ÙÀ½±Û ´Ü±¹´ëÇб³º´¿ø Zap-X °³¼Ò ±â³ä ½ÉÆ÷Áö¿ò : 2024-01-26
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20895 °æ±â ¿ëÀμ¼ºê¶õ½ºº´¿ø µðÁöÅÐÀÇ·á½ÉÆ÷Áö¾ö -¹Ì·¡ ÀǷḦ À§ÇÑ ±³·ù¿Í Çù·Â : 2024-07-04 0 22 2024-05-28
20894 ¼­¿ï ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ENDO 2024 (Day1) : 2024-07-04 0 12 2024-05-28
20893 ¼­¿ï ´ëÇÑ»êºÎÀΰúÇÐȸ ¼­ºÎÁöȸ Á¤±â Áý´ãȸ(Àڱ󻸷Áõ½ÄÁõ) : 2024-07-02 0 29 2024-05-28
20892 ¼­¿ï ´ëÇѼҾƽÅÀåÇÐȸ (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-01 0 26 2024-05-28
20891 ´ëÀü Ãæ³²´ëÇб³º´¿ø 2024³â °³¿øÀÇ¿Í ÇÔ²²ÇÏ´Â ³»°ú ¿¬¼ö°­Á : 2024-06-30 0 42 2024-05-28
20890 ¼­¿ï ´ëÇѳúÁ¹ÁßÇÐȸ 6¿ù º¸¼ö±³À° : 2024-06-30 0 137 2024-05-27
20889 ¼­¿ï (¿Â¶óÀÎ)Á¦22Â÷ ¼­¿ïƯº°½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-30 0 62 2024-05-27
20888 °æ±â (¿Â¶óÀÎ)Á¦21Â÷ °æ±âµµÀÇ»çȸ ¿Â¶óÀÎ Çмú´ëȸ : 2024-06-30 0 144 2024-05-27
20887 Àü³² 2024³â ´ëÇÑ´ëÀåÇ×¹®ÇÐȸ ¿¬¼ö°­Á : 2024-06-30 0 52 2024-05-27
20886 Ãæ³² ´ëÇÑÁ¤Çü¿Ü°úÃÊÀ½ÆÄÇÐȸ - Á¦19Â÷ Ãá°èÇмú´ëȸ ¹× Á¦38Â÷ ±Ù°ñ°Ý°è ÃÊÀ½ÆÄ¿öÅ©¼¥ (Basic Course) : 2024-06-30 0 30 2024-05-27
20885 ºÎ»ê Á¦3ȸ ´ëÇÑÅõ¼®Çùȸ ºÎ»êÁöȸ ½ÉÆ÷Áö¾ö : 2024-06-29 0 48 2024-05-27
20884 ¼­¿ï Çѱ¹ÁöÁú¤ýµ¿¸Æ°æÈ­ÇÐȸ Á¦7ȸ A to Z (Atherosclerosis to Zero) ¿¬¼ö°­Á ÇÁ·Î±×·¥ : 2024-06-29 0 60 2024-05-27
20883 °æ±â 2024³âµµ ³²¾çÁÖ½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-29 0 30 2024-05-27
20882 ¼­¿ï (¿Â¶óÀÎ)Á¦14ȸ ´ëÇÑ°¨¿°ÇÐȸ Æò»ý±³À° ÇÁ·Î±×·¥ °¨¿°Áúȯ ÃÖ½ÅÁö°ß : 2024-06-29 0 41 2024-05-27
20881 ¼­¿ï Á¦24Â÷ ´ëÇѽÅÀåÇÐȸ ½ÅÀ̽Ŀ¬±¸È¸ ¿¬¼ö°­Á : 2024-06-29 0 22 2024-05-27
11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷